Practice Management

Top Story

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process
November 16, 2017

WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.

“Ninety percent doesn’t sound so good if it’s you,” Gottlieb, now 44, told HemOnc Today following a keynote presentation at the Friends of Cancer Research Annual Meeting. “So, to me, that 10% sounded pretty grim.”

Meeting News

AMA adopts new strategy for genetic tests, therapeutics

November 15, 2017
AMA recently voted to advance the development of a comprehensive strategy that allows more consistent coverage of genomic and genetic tests and precision medicine, a…
Meeting NewsVideo

VIDEO: Significant improvements for skin disease activity seen in patients with dermatomyositis treated with anabasum

November 15, 2017
SAN DIEGO — At the American College of Rheumatology Annual Meeting, Victoria P. Werth, MD, spoke about a study that evaluated the safety and efficacy of…
In the Journals

Rosacea Society offers update on comorbidities, directions of future research

November 15, 2017
The National Rosacea Society Expert Committee recently wrote an update discussing comorbidities of the disease, along with suggested directions for future research. A…
More Headlines »
Advertisement
Advertisement